The availability of 750 microgram parathyroid hormone injection in AU remains restricted, primarily because of its specialized medical application in treating severe osteoporosis. Distribution are largely managed through specialized pharmacies and hospital institutions, demanding a medical order and specialized clinical evaluation. While imported v